Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2018

  • ID: 4516296
  • Report
  • Region: Global
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The researcher announced the results of its Multiple Sclerosis patients study in a new research ‘Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2018’. The research provides insights into Multiple Sclerosis epidemiology, Multiple Sclerosis diagnosed patients, and Multiple Sclerosis treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Multiple Sclerosis derived from epidemiological analysis, patients diagnosed with Multiple Sclerosis, and patients treated with a drug therapy.

The research study helps executives estimate Multiple Sclerosis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Multiple Sclerosis prevalence, Multiple Sclerosis diagnosis rate, and Multiple Sclerosis treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report:
  • Multiple Sclerosis Patient Flow
  • Multiple Sclerosis Prevalence
  • Multiple Sclerosis Diagnosed Patients
  • Multiple Sclerosis Treated Patients
Note: Product cover images may vary from those shown
2 of 3
1. Multiple Sclerosis: Disease Definition
2. Global Multiple Sclerosis Patient Flow
2A. Global Multiple Sclerosis Prevalence
2B. Global Multiple Sclerosis Diagnosed Patients
2C. Global Multiple Sclerosis Treated Patients
3. Multiple Sclerosis Patient Flow in the US
3A. Multiple Sclerosis Prevalence in the US
3B. Multiple Sclerosis Diagnosed Patients in the US
3C. Multiple Sclerosis Treated Patients in the US
4. Multiple Sclerosis Patient Flow in Europe
4A. Multiple Sclerosis Prevalence in Europe
4B. Multiple Sclerosis Diagnosed Patients in Europe
4C. Multiple Sclerosis Treated Patients in Europe
5. Multiple Sclerosis Patient Flow in Germany
5A. Multiple Sclerosis Prevalence in Germany
5B. Multiple Sclerosis Diagnosed Patients in Germany
5C. Multiple Sclerosis Treated Patients in Germany
6. Multiple Sclerosis Patient Flow in France
6A. Multiple Sclerosis Prevalence in France
6B. Multiple Sclerosis Diagnosed Patients in France
6C. Multiple Sclerosis Treated Patients in France
7. Multiple Sclerosis Patient Flow in Spain
7A. Multiple Sclerosis Prevalence in Spain
7B. Multiple Sclerosis Diagnosed Patients in Spain
7C. Multiple Sclerosis Treated Patients in Spain
8. Multiple Sclerosis Patient Flow in Italy
8A. Multiple Sclerosis Prevalence in Italy
8B. Multiple Sclerosis Diagnosed Patients in Italy
8C. Multiple Sclerosis Treated Patients in Italy
9. Multiple Sclerosis Patient Flow in UK
9A. Multiple Sclerosis Prevalence in UK
9B. Multiple Sclerosis Diagnosed Patients in UK
9C. Multiple Sclerosis Treated Patients in UK
10. Multiple Sclerosis Patient Flow in Japan
10A. Multiple Sclerosis Prevalence in Japan
10B. Multiple Sclerosis Diagnosed Patients in Japan
10C. Multiple Sclerosis Treated Patients in Japan
11. Research Methodology

List of Tables
Table 1: Global Multiple Sclerosis Patient Flow, 2017
Table 2: Global Multiple Sclerosis Patient Flow Forecast, 2017 - 2026
Table 3: Multiple Sclerosis Patient Flow in the US, 2017
Table 4: Multiple Sclerosis Patient Flow Forecast in the US, 2017 - 2026
Table 5: Multiple Sclerosis Patient Flow in Europe, 2017
Table 6: Multiple Sclerosis Patient Flow Forecast in Europe, 2017 - 2026
Table 7: Multiple Sclerosis Patient Flow in Germany, 2017
Table 8: Multiple Sclerosis Patient Flow Forecast in Germany, 2017 - 2026
Table 9: Multiple Sclerosis Patient Flow in France, 2017
Table 10: Multiple Sclerosis Patient Flow Forecast in France, 2017 - 2026
Table 11: Multiple Sclerosis Patient Flow in Spain, 2017
Table 12: Multiple Sclerosis Patient Flow Forecast in Spain, 2017 - 2026
Table 13: Multiple Sclerosis Patient Flow in Italy, 2017
Table 14: Multiple Sclerosis Patient Flow Forecast in Italy, 2017 - 2026
Table 15: Multiple Sclerosis Patient Flow in UK, 2017
Table 16: Multiple Sclerosis Patient Flow Forecast in UK, 2017 - 2026
Table 17: Multiple Sclerosis Patient Flow in Japan, 2017
Table 18: Multiple Sclerosis Patient Flow Forecast in Japan, 2017 - 2026

List of Figures
Figures 1: Global Multiple Sclerosis Patient Flow, 2017
Figure 2: Global Multiple Sclerosis Patient Flow Forecast, 2017 - 2026
Figure 3: Multiple Sclerosis Patient Flow in the US, 2017
Figure 4: Multiple Sclerosis Patient Flow Forecast in the US, 2017 - 2026
Figure 5: Multiple Sclerosis Patient Flow in Europe, 2017
Figure 6: Multiple Sclerosis Patient Flow Forecast in Europe, 2017 - 2026
Figure 7: Multiple Sclerosis Patient Flow in Germany, 2017
Figure 8: Multiple Sclerosis Patient Flow Forecast in Germany, 2017 - 2026
Figure 9: Multiple Sclerosis Patient Flow in France, 2017
Figure 10: Multiple Sclerosis Patient Flow Forecast in France, 2017 - 2026
Figure 11: Multiple Sclerosis Patient Flow in Spain, 2017
Figure 12: Multiple Sclerosis Patient Flow Forecast in Spain, 2017 - 2026
Figure 13: Multiple Sclerosis Patient Flow in Italy, 2017
Figure 14: Multiple Sclerosis Patient Flow Forecast in Italy, 2017 - 2026
Figure 15: Multiple Sclerosis Patient Flow in UK, 2017
Figure 16: Multiple Sclerosis Patient Flow Forecast in UK, 2017 - 2026
Figure 17: Multiple Sclerosis Patient Flow in Japan, 2017
Figure 18: Multiple Sclerosis Patient Flow Forecast in Japan, 2017 - 2026
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll